Balchem Corp. (NASDAQ:BCPC) General Counsel Matthew David Houston sold 4,000 shares of the stock in a transaction that occurred on Tuesday, September 20th. The shares were sold at an average price of $67.83, for a total transaction of $271,320.00. Following the sale, the general counsel now directly owns 20,050 shares in the company, valued at $1,359,991.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Shares of Balchem Corp. (NASDAQ:BCPC) opened at 70.45 on Monday. The company has a market capitalization of $2.23 billion, a PE ratio of 40.03 and a beta of 0.70. Balchem Corp. has a 1-year low of $53.11 and a 1-year high of $70.92. The stock’s 50 day moving average is $67.86 and its 200 day moving average is $62.94.
Balchem Corp. (NASDAQ:BCPC) last issued its quarterly earnings data on Friday, August 5th. The company reported $0.44 earnings per share for the quarter, missing the consensus estimate of $0.65 by $0.21. Balchem Corp. had a return on equity of 16.85% and a net margin of 10.18%. The business earned $138.80 million during the quarter, compared to analyst estimates of $134.77 million. On average, equities research analysts anticipate that Balchem Corp. will post $2.53 EPS for the current fiscal year.
Separately, Pivotal Research reissued a “hold” rating and set a $65.00 price target on shares of Balchem Corp. in a research note on Sunday, August 7th.
About Balchem Corp.
Balchem Corporation (Balchem) is engaged in the development, manufacture, distribution and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. The Company operates in four segments: SensoryEffects, Animal Nutrition & Health (ANH), Specialty Products and Industrial Products.
Receive News & Ratings for Balchem Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem Corp. and related companies with MarketBeat.com's FREE daily email newsletter.